Status:
ACTIVE_NOT_RECRUITING
Predictive Assays In Cervix Cancer
Lead Sponsor:
University Health Network, Toronto
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The experiments outlined in this proposal will compare a number of currently available techniques for assessing hypoxia and interstitial fluid pressures in patients with cervix cancer. The aim of thes...
Eligibility Criteria
Inclusion
- Histologic diagnosis of cervix cancer
- A decision to treat using radiation therapy according to the existing treatment policies of the PMH Gynecology Group
- Clinical stage IB-IV with grossly evident cervical disease
- No distant metastases
- No cytotoxic anti-cancer therapy for cervical carcinoma prior to study entry
- Signed informed consent
Exclusion
- \-
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01181375
Start Date
August 1 2006
End Date
August 1 2027
Last Update
February 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network, Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9